ロード中...
Combination therapy with HSP90 inhibitor 17-DMAG reconditions the tumor microenvironment to improve recruitment of therapeutic T cells()
Ineffective recognition of tumor cells by CD8(+) T cells is a limitation of cancer immunotherapy. Therefore, treatment regimens that coordinately promote enhanced anti-tumor CD8(+) T cell activation, delivery, and target cell recognition should yield greater clinical benefit. Using an MCA205 sarcoma...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3389149/ https://ncbi.nlm.nih.gov/pubmed/22552283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-0538 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|